News

Pharmabiz4m
UK MHRA approves Janssen-Cilag’s guselkumab for Crohn’s disease and ulcerative colitis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) to treat Crohn’s disease and ulcerative colitis (UC). The approval was granted on 16th May, 2025 to ...
Pharmabiz5h
PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils
PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils: Gireesh Babu, New Delhi ...
Pharmabiz5h
SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug
SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug: Gireesh Babu, New Delhi Monday, ...
Pharmabiz2h
BioMarin enters agreement to acquire Inozyme Pharma for $270 million
BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a total ...
Pharmabiz3h
EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant
EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...
Pharmabiz4h
Indian Pharmaceutical Congress 2025 calls for registration of participants under four categories
Indian Pharmaceutical Congress 2025 calls for registration of participants under four categories: Our Bureau, Bengaluru Monday, May 19, 2025, 09:00 Hrs [IST] The 74th Indian Pharm ...
Pharmabiz5h
Healthcare sector convinced on precision testing and tech-led monitoring changing medical treatment landscape
Healthcare sector convinced on precision testing and tech-led monitoring changing medical treatment landscape: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Medical centres in India emphase on protection of sensitive patient data as top priority
Medical centres in India emphase on protection of sensitive patient data as top priority: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] Medical centres in t ...
Pharmabiz5h
LUB asks Centre to constitute Drug Tribunal Board to address industry grievances
LUB asks Centre to constitute Drug Tribunal Board to address industry grievances: Peethaambaran Kunnathoor, Chennai Monday, May 19, 2025, 08:00 Hrs [IST] The Laghu Udyog Bharati ( ...
Pharmabiz3d
KPRDO urges govt to exempt drug licenses from stamp duty
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has underscored the need to review the notices issued to ...
Pharmabiz2d
Indian cos are expanding their presence in RoW markets due to strong demand, less competition: Nilesh Patel
Indian cos are expanding their presence in RoW markets due to strong demand, less competition: Nilesh Patel: Shardul Nautiyal, Mumbai Saturday, May 17, 2025, 08:00 Hrs [IST] India ...
Pharmabiz2d
China pharma advances from ‘imitation to innovation’ to propel global pharma pipelines: Dr Sheryl Ding
China pharma advances from ‘imitation to innovation’ to propel global pharma pipelines: Dr Sheryl Ding: Nandita Vijayasimha, Bengaluru Saturday, May 17, 2025, 08:00 Hrs [IST] ...